Analyst Valuation and EPS Growth for NYSE:RYI, NYSE:DCI, NYSE:MSC, NASDAQ:LTRN

RYERSON (NYSE:RYI) EARNINGS INFORMATION (NYSE:RYI)

Ryerson last posted its earnings results on February 23rd, 2021. The basic materials company reported ($0.17) EPS for the quarter, missing the consensus estimate of $0.37 by $0.54. Ryerson has generated $1.79 earnings per share over the last year. Ryerson has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, May 5th, 2021 based off prior year’s report dates.

IS RYERSON A BUY RIGHT NOW? (NYSE:RYI)

3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Ryerson in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Ryerson stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYI, but not buy additional shares or sell existing shares.
Ryerson

DONALDSON (NYSE:DCI) EARNINGS INFORMATION (NYSE:DCI)

Donaldson last released its quarterly earnings data on February 25th, 2021. The industrial products company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.51 by $0.01. Donaldson has generated $2.00 earnings per share over the last year and currently has a price-to-earnings ratio of 30.3.

IS DONALDSON A BUY RIGHT NOW? (NYSE:DCI)

5 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Donaldson in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Donaldson stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DCI, but not buy additional shares or sell existing shares.
Donaldson

STUDIO CITY INTERNATIONAL EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NYSE:MSC)

IS STUDIO CITY INTERNATIONAL A BUY RIGHT NOW? (NYSE:MSC)

1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Studio City International in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should “buy” Studio City International stock.
Studio City International

LANTERN PHARMA EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:LTRN)

IS LANTERN PHARMA A BUY RIGHT NOW? (NASDAQ:LTRN)

2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Lantern Pharma in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Lantern Pharma stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LTRN, but not buy additional shares or sell existing shares.
Lantern Pharma